NWBOW
Northwest Biotherapeutics, Inc.
NWBOW
NWBOW
Delisted
NWBOW was delisted on the 16th of December, 2016.
4 hedge funds and large institutions have $455K invested in Northwest Biotherapeutics, Inc. in 2014 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
4
Holders Change
–
Holders Change %
0%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
U
UBS
Zurich,
Switzerland
|
$1K |
Top Sellers
| 1 |
SHGA
Sand Hill Global Advisors
Palo Alto,
California
|
$0 |
| 2 |
AIG
American International Group
New York
|
$17K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
1
Allianz Asset Management
Munich,
Germany
| $437K | – | – | – |
|
|
AIG
2
American International Group
New York
| $17K | -$14.6K | -3,000 | -46% |
|
|
U
3
UBS
Zurich,
Switzerland
| $1K | +$1K | +158 | New |
|
|
SHGA
4
Sand Hill Global Advisors
Palo Alto,
California
| – | -$35K | -12,500 | Closed |
|